Nanobiotix highlights ASTRO research studies
October 7, 2021 -- Nanobiotix will present results from clinical trials of its NBTXR3 radioenhancer at the 2021 American Society for Radiation Oncology (ASTRO) meeting, which will be held October 24-27 in Chicago. Read More
ViewRay submits 510(k) for updated version of MRIdian
October 4, 2021 -- Image-guided radiation therapy vendor ViewRay has submitted a 510(k) application for an updated version of its MRIdian MRI-guided radiation therapy system. Read More
Accuray inks collaboration with C-RAD
October 4, 2021 -- Radiation therapy firm Accuray has signed a collaboration agreement with C-RAD to incorporate C-RAD's Catalyst+ HD software into Accuray's Radixact breast cancer radiation therapy treatment system. Read More
Siemens, MD Anderson create MRI for rad therapy program
September 29, 2021 -- Siemens Healthineers and the University of Texas MD Anderson Cancer Center have developed a global education program to enable consistent implementation of MRI in radiation oncology. Read More
ASTRO urges members to oppose Medicare payment cuts
September 27, 2021 -- The American Society for Radiation Oncology (ASTRO) is urging its members to contact their representatives in the U.S. Congress to scale back cuts proposed by Medicare in reimbursement for radiation oncology services. Read More
Theragnostics enters licensing deal with AAA for Ga-68 PET
September 22, 2021 -- Theragnostics has signed a global licensing agreement with Advanced Accelerator Applications (AAA) to develop and commercialize gallium-68 (Ga-68) one-step PET radiopharmaceuticals. Read More
Radiation therapy for breast cancer boosts risk of heart disease
September 21, 2021 -- Women who undergo radiation therapy to the left side of the chest to treat breast cancer are at twice the risk for coronary artery disease, according to research published September 21 in the Journal of the American College of Cardiology. Read More
BWXT and Bayer to focus on therapeutic radionuclides
September 16, 2021 -- BWXT Medical and Bayer have entered an agreement to ramp up their supply of actinium-225 as both companies seek to broaden commercialization strategies for targeted radionuclide therapies. Read More
IBA, SCK CEN sign actinium-225 deal
September 15, 2021 -- Proton therapy developer Ion Beam Applications (IBA) and Belgian nuclear research center SCK CEN have partnered to enable the production of the medical radioisotope actinium-225. Read More
Accuray promotes prostate cancer research at ESTRO 2021
September 14, 2021 -- Radiation oncology firm Accuray is highlighting research presented at the recent European Society for Radiotherapy and Oncology (ESTRO) annual congress on the benefits of its CyberKnife robotic radiotherapy platform in prostate cancer treatment. Read More
Special Feature
IMV: Imaging boosts precision in radiation therapy

Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more